Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial

Am J Clin Nutr. 2011 Dec;94(6 Suppl):1776S-1784S. doi: 10.3945/ajcn.110.000596. Epub 2011 Aug 17.

Abstract

Background: Protein intake in early infancy has been suggested to be an important risk factor for later obesity, but information on potential mechanisms is very limited.

Objective: This study examined the influence of protein intake in infancy on serum amino acids, insulin, and the insulin-like growth factor I (IGF-I) axis and its possible relation to growth in the first 2 y of life.

Design: In a multicenter European study, 1138 healthy, formula-fed infants were randomly assigned to receive cow-milk-based infant and follow-on formulas with lower protein (LP; 1.77 and 2.2 g protein/100 kcal) or higher protein (HP; 2.9 and 4.4 g protein/100 kcal) contents for the first year. Biochemical variables were measured at age 6 mo in 339 infants receiving LP formula and 333 infants receiving HP formula and in 237 breastfed infants.

Results: Essential amino acids, especially branched-chain amino acids, IGF-I, and urinary C-peptide:creatinine ratio, were significantly (P < 0.001) higher in the HP group than in the LP group, whereas IGF-binding protein (IGF-BP) 2 was lower and IGF-BP3 did not differ significantly. The median IGF-I total serum concentration was 48.4 ng/mL (25th, 75th percentile: 27.2, 81.8 ng/mL) in the HP group and 34.7 ng/mL (17.7, 57.5 ng/mL) in the LP group; the urine C-peptide:creatinine ratios were 140.6 ng/mg (80.0, 203.8 ng/mg) and 107.3 ng/mg (65.2, 194.7 ng/mg), respectively. Most essential amino acids, IGF-I, C-peptide, and urea increased significantly in both the LP and HP groups compared with the breastfed group. Total IGF-I was significantly associated with growth until 6 mo but not thereafter.

Conclusions: HP intake stimulates the IGF-I axis and insulin release in infancy. IGF-I enhances growth during the first 6 mo of life. This trial was registered at clinicaltrials.gov as NCT00338689.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids, Branched-Chain / blood
  • Animals
  • Biomarkers
  • Blood Glucose / analysis
  • Breast Feeding
  • C-Peptide / blood
  • C-Peptide / urine
  • Child Development
  • Creatinine / blood
  • Double-Blind Method
  • Endocrine System / drug effects*
  • Endocrine System / metabolism*
  • Energy Intake
  • Female
  • Humans
  • Infant
  • Insulin-Like Growth Factor Binding Protein 3 / blood
  • Insulin-Like Growth Factor I / analysis
  • Male
  • Milk
  • Milk Proteins / administration & dosage*
  • Milk Proteins / analysis
  • Obesity / epidemiology
  • Obesity / prevention & control
  • RNA-Binding Proteins / blood
  • Risk Factors
  • White People

Substances

  • Amino Acids, Branched-Chain
  • Biomarkers
  • Blood Glucose
  • C-Peptide
  • IGF2BP2 protein, human
  • IGFBP3 protein, human
  • Insulin-Like Growth Factor Binding Protein 3
  • Milk Proteins
  • RNA-Binding Proteins
  • Insulin-Like Growth Factor I
  • Creatinine

Associated data

  • ClinicalTrials.gov/NCT00338689